Excellent Long-Term Data for TYK2 Inhibitor ESK-001 in Psoriasis
The investigational tyrosine kinase 2 (TYK2) inhibitor ESK-001 was well tolerated and displayed promising efficacy data in a phase 2 including patients with moderate-to-severe plaque psoriasis. A phase...
View ArticleAddressing Sleep & Mental Health in Patients With Psoriasis
Authors of an abstract presented at the 2025 AAD Annual Meeting said collaborating with patients “is essential” for addressing sleep disturbances and mental health comorbidities, which are...
View ArticleManaging Nutritional Deficiencies & Weight Regain in Bariatric Surgery
Researchers laid out nutritional management strategies for clinicians to offer patients before and after bariatric surgery to help sustain weight loss. Bariatric surgery is an effective treatment to...
View ArticleQuiz: What Are the Personalized Treatments for Breast Cancer?
How Much Do You Know About Personalized & Targeted Therapies for Breast Cancer? The post Quiz: What Are the Personalized Treatments for Breast Cancer? first appeared on Physician's Weekly.
View ArticleSocial Vulnerability and Racial Disparities in Penicillin Allergy Labels
The following is a summary of “Association of Social Determinants of Health and Penicillin Allergy Labels: a case-control study,” published in the March 2025 issue of Clinical Infectious Diseases by...
View ArticleAccuracy of POCUS for Pneumoperitoneum Detection
The following is a summary of “Emergency physician ultrasound diagnosis of pneumoperitoneum in intraoperative patients with peritoneal insufflation,” published in the April 2025 issue of American...
View ArticleChallenges in Fluid Management and Outcomes in VA-ECMO
The following is a summary of “Fluid management in adult patients undergoing venoarterial extracorporeal membrane oxygenation: A scoping review,” published in the April 2025 issue of Journal of...
View ArticleClik here to view.
FDA Approves First At-Home Test to Diagnose Three STIs in Women
TUESDAY, April 1, 2025 (HealthDay News) — The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and...
View ArticleClik here to view.
Common Photosensitizing Drugs Increase Skin Cancer Risk
TUESDAY, April 1, 2025 (HealthDay News) — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology...
View ArticleClik here to view.
Stimulant Involvement in Opioid OD Death Higher for Those in Physically...
TUESDAY, April 1, 2025 (HealthDay News) — A higher percentage of individuals who have psychostimulant involvement in synthetic opioid overdose deaths tend to work in physically demanding occupations...
View ArticleClik here to view.
Prevalence of Prescription Stimulant Misuse High in U.S. Adults
TUESDAY, April 1, 2025 (HealthDay News) — The prevalence of prescription stimulant misuse and prescription stimulant use disorder (PSUD) is high among U.S. adults aged 18 to 64 years, according to a...
View ArticleClik here to view.
Subclinical Cardiac Dysfunction Linked to Markers of Neurodegeneration
TUESDAY, April 1, 2025 (HealthDay News) — Subclinical cardiac dysfunction is associated with brain imaging markers of neurodegeneration, according to a study published online March 26 in Neurology....
View ArticleClik here to view.
Invasive Bladder Pressure Tests for Refractory Overactive Bladder May Be Avoided
TUESDAY, April 1, 2025 (HealthDay News) — Urodynamics plus comprehensive clinical assessment (CCA) is not superior to CCA only for women with refractory overactive bladder or urgency predominant mixed...
View ArticleClik here to view.
More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022
TUESDAY, April 1, 2025 (HealthDay News) — More than 3.8 million U.S. lung cancer deaths were averted during 1970 to 2022, and more than 76 million person-years of life were gained, according to a study...
View ArticleClik here to view.
AI Model Can Optimize, Standardize Total Parenteral Nutrition Formulas
TUESDAY, April 1, 2025 (HealthDay News) — An artificial intelligence (AI) approach identified total parenteral nutrition (TPN) formulas that increase safety and potentially reduce costs for neonates...
View ArticleClik here to view.
Social Vulnerability Index Linked to Risk for Alzheimer Disease
TUESDAY, April 1, 2025 (HealthDay News) — Individuals who live in areas with a higher social vulnerability index (SVI) have an increased risk for incident Alzheimer disease (AD) and a faster rate of...
View ArticleClik here to view.
Similar Efficacy Seen for Isodose, Dose-Escalated MHFRT, CFRT in Prostate Cancer
TUESDAY, April 1, 2025 (HealthDay News) — For patients with prostate cancer, isodose and dose-escalated moderately hypofractionated radiotherapy (MHFRT) have similar efficacy as conventionally...
View ArticleClik here to view.
Brain Implant Lets Woman Talk After 18 Years of Silence Due to Stroke
TUESDAY, April 1, 2025 (HealthDay News) — For nearly two decades, a stroke had left a woman unable to speak — until now. Thanks to a new brain implant, her thoughts are being turned into real-time...
View ArticleClik here to view.
Major Job Cuts at NIOSH Pose Risks to Worker Safety, Critics Warn
TUESDAY, April 1, 2025 (HealthDay News) — A major round of job cuts at the National Institute for Occupational Safety and Health (NIOSH) could weaken efforts to protect American workers, according to...
View ArticleAge-Related Decline in Placebo Hypoalgesia and Executive Functioning
The following is a summary of “Placebo Hypoalgesic Response Is Reduced in Healthy Older Adults Showing a Decline in Executive Functioning,” published in the April 2025 issue of Journal of Pain Research...
View Article